-
Mashup Score: 0Vol 10, No 6 (December 2021) - Chinese Clinical Oncology - 2 year(s) ago
The Chinese Clinical Oncology publishes articles that describe new findings in the field of oncology, provides current and practical information on diagnosis, prevention and clinical investigations of cancer.
Source: cco.amegroups.comCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 1Overall Rates of Reconstructive Breast Surgery for Women With Inflammatory Breast Cancer Undergoing Mastectomy Remain Low - 3 year(s) ago
PHILADELPHIA (July 23, 2021) – The percentage of inflammatory breast cancer (IBC) patients selecting reconstructive surgery after mastectomy, whether immediate or delayed, remains low in spite of improvements in treatment and long-term survival, but the numbers are increasing, according to recent research.
Source: www.foxchase.orgCategories: Latest Headlines, Oncologists1Tweet-
We do not recommend immediate reconstruction for inflammatory breast cancer as a standard of care. The risk of disease recurrence is high. Surgical complications can delay other essential treatment that can reduce the chance of relapse. #TalkIBC #bcsm https://t.co/bBI5KvH7uz
-
-
Mashup Score: 0Inflammatory breast cancer appearance at presentation is associated with overall survival - 3 year(s) ago
Inflammatory breast cancer (IBC) is a clinical diagnosis. Here, we examined the association of a “classic” triad of clinical signs, swollen involved breast, nipple change, and diffuse skin change, wi…
Source: Wiley Online LibraryCategories: Latest Headlines, Oncologists1Tweet-
IBC is a clinical diagnosis. The “classic” triad of clinical signs, swollen involved breast, nipple change, and diffuse skin changes reflects poorer outcome with overall survival compared to those who do not have triad symptoms. #bcsm #talkIBC https://t.co/BUFJYFzHze
-
-
Mashup Score: 1
Background Inflammatory breast cancer (IBC) is a rare breast malignancy with poor outcomes compared with non-IBC. Age-related differences in tumor biology, treatment, and clinical outcomes have been described in non-IBC. This study evaluated age-related differences in IBC. Methods From an institutional prospective database, patients with an IBC diagnosed from 2010 to 2019 were identified. Age was…
Source: Annals of Surgical OncologyCategories: Latest Headlines, Oncologists1Tweet-
The data suggest that there is no reason to de-escalate the treatments for inflammatory breast cancer because of age. #bcsm #talkIBC https://t.co/Mv3hCKH2ny
-
-
Mashup Score: 0Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancer - 3 year(s) ago
Inflammatory breast cancer (IBC) is the most aggressive form of breast cancer. Although it is a rare subtype, IBC is responsible for roughly 10% of breast cancer deaths. In order to obtain a better understanding of the genomic landscape and intratumor heterogeneity (ITH) in IBC, we conducted whole-exome sequencing of 16 tissue samples (12 tumor and four normal samples) from six…
Source: npj Breast CancerCategories: Hem/Oncs, Latest HeadlinesTweet-
Two papers on whole exosome sequencing of inflammatory breast cancer. We still do not know how to translate this into the clinic or link it to a biological meaning. :( https://t.co/1JtdHAEff2 and https://t.co/6n1YkS8f4Y #TalkIBC #bcsm
-
“Why and What” for the optimal management of inflammatory breast cancer. These articles will help you understand how we treat our patients with IBC at IBC clinics in the USA. #bcsm #talkIBC https://t.co/Y8i7KJCh6r